Authors: Dal Maso, L., Franceschi, S., La Vecchia, C., Levi, F., Malerba, S., Montella, M., Pelucchi, C., Serraino, D., Tavani, A., Zambon, A., Zucchetto, A.
Published: August 2, 2017
In a network of case-control studies from Italy and Switzerland (1991-2009) with 505 esophageal cancer cases, dietary folate showed the strongest inverse association among all cancer sites examined. An increment of 100μg/day of dietary folate yielded an odds ratio of 0.58, representing a 42% risk reduction. Odds ratios were estimated using multiple logistic regression models adjusted for major identified confounding factors. The association remained consistent across subgroups defined by sex, age, smoking status, and alcohol consumption.
